VRXWF yields 200.00% · PFE yields 6.13%● Live data
📍 VRXWF pulled ahead of the other in Year 1
Combined, VRXWF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VRXWF + PFE for your $10,000?
MediaValet Inc. develops and licenses enterprise cloud software to medium sized enterprise businesses. It offers Enterprise Digital Asset Management (DAM) platform that helps to create, find, work with, manage, and share digital assets; CreativeSPACES, a hybrid cloud/on premise tool for collaborating between team members, the core DAM, and other media creation software; and other modules for advanced artificial intelligence, audio/video intelligence, mobile support, content publishing, and open application programming interface developer tools. The company also provides systems for workflow management, content management, customer relationship management, social media management, office productivity, and security. It serves healthcare, education, manufacturing, government, and not-for-profit organizations. The company was formerly known as VRX Worldwide Inc. MediaValet Inc. was incorporated in 1993 and is headquartered in Vancouver, Canada.
Full VRXWF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.